Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

2010
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 2
2013 2
2014 1
2015 1
2016 2
2017 5
2018 5
2019 3
2020 2
2021 2
2022 1
2023 3
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.
Swindells S, Ramchandani R, Gupta A, Benson CA, Leon-Cruz J, Mwelase N, Jean Juste MA, Lama JR, Valencia J, Omoz-Oarhe A, Supparatpinyo K, Masheto G, Mohapi L, da Silva Escada RO, Mawlana S, Banda P, Severe P, Hakim J, Kanyama C, Langat D, Moran L, Andersen J, Fletcher CV, Nuermberger E, Chaisson RE; BRIEF TB/A5279 Study Team. Swindells S, et al. N Engl J Med. 2019 Mar 14;380(11):1001-1011. doi: 10.1056/NEJMoa1806808. N Engl J Med. 2019. PMID: 30865794 Free PMC article. Clinical Trial.
Breast cancer diagnosis in a resource poor environment through a collaborative multidisciplinary approach: the Kenyan experience.
Sayed S, Moloo Z, Bird P, Wasike R, Njoroge W, Karanu J, Nzioka A, Sherman O, Prasad S, Mariwa C, Otieno JO, Chumba D, Koech D, Mbinga D, Mohammed M, Njoroge R, Chauhan R, Vinayak S, Kyobutungi C, Saleh M. Sayed S, et al. Among authors: nzioka a. J Clin Pathol. 2013 Apr;66(4):307-11. doi: 10.1136/jclinpath-2012-201404. Epub 2013 Feb 1. J Clin Pathol. 2013. PMID: 23378268
Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial.
Hakim JG, Thompson J, Kityo C, Hoppe A, Kambugu A, van Oosterhout JJ, Lugemwa A, Siika A, Mwebaze R, Mweemba A, Abongomera G, Thomason MJ, Easterbrook P, Mugyenyi P, Walker AS, Paton NI; Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team. Hakim JG, et al. Lancet Infect Dis. 2018 Jan;18(1):47-57. doi: 10.1016/S1473-3099(17)30630-8. Epub 2017 Nov 3. Lancet Infect Dis. 2018. PMID: 29108797 Free PMC article. Clinical Trial.
Wilms tumor survival in Kenya.
Axt J, Abdallah F, Axt M, Githanga J, Hansen E, Lessan J, Li M, Musimbi J, Mwachiro M, Newton M, Ndung'u J, Njuguna F, Nzioka A, Oruko O, Patel K, Tenge R, Ukoli F, White R, O'Neill JA Jr, Lovvorn HN 3rd. Axt J, et al. Among authors: nzioka a. J Pediatr Surg. 2013 Jun;48(6):1254-62. doi: 10.1016/j.jpedsurg.2013.03.021. J Pediatr Surg. 2013. PMID: 23845615 Free PMC article.
Ethnicity and breast cancer characteristics in Kenya.
Sayed S, Moloo Z, Wasike R, Bird P, Oigara R, Njoroge FW, Shaikh AJ, Prasad SV, Vinayak S, Gierach GL, Dawsey SM, Palakal M, Fan S, Mullooly M, Chauhan R, Okiro P, Gakinya S, Nzioka A, Kyobutungi C, Mohamed S, Haregu T, Mussajee M, Bonass B, Mariwa C, Sherman OA, Mohammed A, Gachii A, Githaiga J, Karanu J, Nyagah R, Njoroge R, Muramba I, Otieno JO, Raburu DO, Mwachiro EB, Abayo I, Saleh M. Sayed S, et al. Among authors: nzioka a. Breast Cancer Res Treat. 2018 Jan;167(2):425-437. doi: 10.1007/s10549-017-4511-2. Epub 2017 Sep 26. Breast Cancer Res Treat. 2018. PMID: 28951987 Free PMC article.
Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial.
Lockman S, Hughes M, Sawe F, Zheng Y, McIntyre J, Chipato T, Asmelash A, Rassool M, Kimaiyo S, Shaffer D, Hosseinipour M, Mohapi L, Ssali F, Chibowa M, Amod F, Halvas E, Hogg E, Alston-Smith B, Smith L, Schooley R, Mellors J, Currier J; OCTANE (Optimal Combination Therapy After Nevirapine Exposure) ACTG A5208/OCTANE Study Team. Lockman S, et al. PLoS Med. 2012;9(6):e1001236. doi: 10.1371/journal.pmed.1001236. Epub 2012 Jun 12. PLoS Med. 2012. PMID: 22719231 Free PMC article. Clinical Trial.
26 results